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ABSTRACT 
In the period 1991-2005, 169 patients with the diagnosis of malaria were 
hospitalized in the Department of Tropical and Parasitic Diseases, Institute of Maritime 
and Tropical Medicine in Gdynia (from 2003 – the Academic Centre of Maritime and 
Tropical Medicine, Medical University of Gdańsk). All the cases were analysed for 
severity, occurrence of complications and permanent sequelae of the disease.   
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According to the criteria set by the WHO (5), malaria was classified as severe in 36 
cases. All of them were  Plasmodium falciparum infections or mixed infections: P.f. and 
another species of the parasite. Patients in this group developed a number of 
complications, inter alia shock, acute respiratory distress syndrome (ARDS), acute renal 
failure, blackwater fever, severe anemia, disseminated intravascular coagulation, 
myocarditis, consciousness disorders of varied degree, acute transient psychoses, and 
exacerbation of ischemic heart disease. In one case of a pregnant woman, necrosis of the 
fetus occurred in the course of disease in the 4th month of pregnancy. Moreover, 
meningoencephalitis was diagnosed in two patients – in one of them concurrently with 
symptoms and signs of malaria, while in the other one - 3 weeks after the symptoms 
subsided. 
In 6 patients, permanent sequelae of the disease developed and in 4 patients the 
disease was fatal. The cause of death was multi-organ failure, with the first sign of poor 
prognosis being rapidly progressing renal failure resistant to treatment in three men; in 
one case death resulted from cerebral malaria. 
In cases of suspected malaria, relapsing malaria or in mixed infections, molecular 
testing  was a  valuable complementary tool of diagnosis, which helped in beginning the 
appropriate treatment. 
INTRODUCTION 
 
In spite of the progress in the diagnostic techniques and treatment of malaria, the 
incidence of the disease  is not decreasing. In Africa, it is increasing in many areas, and 
new cases are reported even in some regions where from the disease had already been 
previously eradicated (1). 
 Malaria continues to be a major health hazard for people visiting tropical regions as 
tourists or staying there for long periods to work there.  
For the indigenous population of endemic regions,  and particularly for children up 
to 5 years of age, pregnant women, HIV-positive patients and people living in 
conditions of extreme poverty, malaria continues to be a serious health hazard. 
In total, the malarious areas in 107 countries of the world are inhabited by 3.2 billion 
people, which accounts for nearly half of the entire population of the globe. Of this 
number, each year about 350-500 million people are infected and more than 1 million of 
them die. More than 90% of these deaths occur in Africa, where the disease is the most 
important cause of deaths among infants and young children (2). Malaria is endemic 
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Africa, Southeast Asia, Central Asia, Middle East, South and Central America, the 
Caribbean Islands and Oceania. Local transmission also occurs in North America.  
In Western Europe about 12 000 new cases of malaria are recorded every year, all of 
them are imported infections (3). 
The control of malaria in the world present many problems. 
Rapidly progressing resistance of the vector – Anopheles mosquitoe to the most 
frequently used insecticides, as well as widespread resistance of the parasite to 
antimalarial drugs, particularly to the cheapest and safest agent – chloroquine, shortage 
of funds for malaria eradication or control programmes, and low level of financing the 
health services in the endemic countries are just some reasons why the struggle against 
malaria has not been successful (4). 
According to data published by the WHO, severe forms of malaria with 
complications and multi-organ failure develop in about 1% of P.falciparum infected 
people, and very rarely - in patients with malaria caused by other species of the parasite. 
In line with the definition formulated by experts, severe form of malaria is 
diagnosed in patients exhibiting one or more of the following signs and symptoms in 
combination with parasite presence in the blood (5): 
 
• disorders of consciousness 
• cerebral malaria (cerebral coma) 
• severe normocytic anemia: hemoglobin (HGB) < 5 g/dL and HCT < 15 % – for 
residents of endemic regions or HGB < 7 g/dL and hematocrit (HCT) < 20% – 
for overseas travelers (non-immunized) 
• renal failure (creatinine > 3 mg/dL) – without improvement after hydration 
• pulmonary edema (acute respiratory distress syndrome – ARDS) 
• disseminated intravascular coagulation (bleeding)  
• collapse and shock  
• hypoglycaemia (glycaemia < 40 mg/dL = 2.2 mmol/L) 
• generalized seizures > 2 episodes/24 hrs 
• lactic acidosis – arterial pH < 7.25 or plasma bicarbonate concentration < 15 
µmol/L, lactate concentration in venous blood > 15 mol/L 
• major weakness and prostration 
• macroscopic hemoglobinuria 
• hyperparasitemia (above 5% in non-immune subjects and above 10% in 
residents of endemic regions) 
• jaundice (bilirubin level above 3 mg/dL) 
• hyperpyrexia (rectal temperature above 40 °C with symptoms typical of heat 
stroke) 
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  OBJECTIVE 
The objective of this study was to analyse the course  of malaria in patients treated 
in the Department of Tropical and Parasitic Diseases,  and assess the incidence of  
severe malaria among them,  its complications and permanent sequelae, according to the 
criteria set forth by WHO experts. 
MATERIAL AND METHODS 
In the period 1991-2005, there were 169 malaria patients hospitalized in our 
department. Among them, there were 144 men (85.2%) aged 23-70 years and 25 women 
(14.8%) aged 29-69 years. The  majority of the patients were Poles, they  visited or 
stayed in malaria endemic areas for business reasons. They were mainly seamen, 
missionaries and soldiers (Table 1). Among our patients were also 20 foreigners: 13 
seamen, 3 tourists, 2 teachers, 1 missionary and 1 physician. 
Figure 1. Patients with malaria hospitalized in the period 1991-2005. 
Pf  –  Plasmodium falciparum 
Pv –  Plasmodium vivax 
Pm – Plasmodium malariae 
Po –  Plasmodium ovale 
Pf+ – two species of Plasmodium sp. (mixed malaria) 
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Table 1. Profession of patients in 169 malaria cases hospitalized in the Department of 
Tropical and Parasitic Diseases in Gdynia in the period 1991-2005. 
 
Profession Number of patients Percentage of patient cohort (%) 
Seaman 88 52.1 
Missionary 39 23.1 
Tourist 21 12.4 
Soldier 7 4.1 
Airline staff member 5 2.9 
Traveller 4 2.4 
Teacher 2 1.2 
Physician 1 0.6 
Forester 1 0.6 
Botanist 1 0.6 
 
Most of the patients were infected  in Central and West Africa (129 cases); others - 
in Arabian Peninsula (11 cases), and Southeast Asia (10 cases); only few people were 
infected on other continents (Table 2). 
The parasite was Plasmodium falciparum in 119 , P. vivax – in 35 , P. malariae – in 
5, and P. ovale – in 3 patients; in 7 cases mixed infection was diagnosed: P. falciparum  
+ P. vivax – in 5 cases, P. falciparum + P. malariae – in 1  and P. falciparum + P. ovale 
– also in 1 case. (Fig. 1). 
Following the WHO criteria, in 36 patients (21.3%) severe malaria was diagnosed. 
 In this group, there were 31 men (86.1%) aged 23-70 years and 5 women (13.9%) 
aged 36-69 years, all of then Poles.   All these cases were P. falciparum infections: in 
30 cases only P.f. as a single parasite, in 4 cases mixed infection with P. vivax, in 1 case 
-  with P. malariae and also in 1 case - with P. ovale. 
Methods employed in the diagnosis of the disease and the responsible parasite 
species included: 
1. Microscopic blood examination (thick drop and thin smear), with Giemsa 
staining 
2. Detection of Plasmodium sp. antigens in venous blood with the use of Optimal 
Malaria Rapid Test (producer DiaMed AG) 
3. Molecular assays (PCR) 
4. ELISA serological test 
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RESULTS 
 
Seamen were the largest professional sub-group among our patients who were 
treated for in the 1990ties, accounting for over 65% of them. In the group of 40 patients 
treated in 2000-2005, there were 10 seamen, 11 missionaries and 8 tourists;  among 
remaining 11 patients were people of other professions. 
36 cases of severe malaria were analysed, they accounted for 21.3 % of all patients 
hospitalized.  All of them were infected  in Africa. In this group, various complications 
were recorded: severe anemia requiring blood transfusion – in 13 patients, shock – in 7 
patients, acute renal failure – in 7 patients, including blackwater fever in 2 cases, 
disseminated intravascular coagulation – in 4 patients and acute respiratory distress 
syndrome (ARDS) in 3 patients, myocarditis in 2 cases, and meningoencephalitis also in 
2 cases (Table 3). In one pregnant woman, who was infected in the 4th month of 
pregnancy, death of the fetus occurred and disseminated intravascular coagulation 
developed. In three patients we observed exacerbation of ischemic heart disease, and in 
two others – acute transient psychoses. 
Duration of hospitalization was generally long; it was shorter than 10 days in 8 
patients only, including three fatal cases when hospital stay lasted 11 hours, 4 days and 
5 days, respectively. In other cases, the duration of stay in hospital varied from 11 to 66 
days, with mean period of 18.7 days. 
Table 2. The origin of imported malaria infections in 169 patients treated in Gdynia. 
 
Continent Number of patients Percentage of patient cohort (%) 
Africa 129 76.3 
Arabian Peninsula 11 6.5 
Southeast Asia 10 5.9 
Central Asia 7 4.1 
South America 6 3.6 
Central America 3 1.8 
Oceania 3 1.8 
In a number of patients, permanent sequelae of the disease were observed, most 
frequently in the form of lesions to the central nervous system, myocardial damage 
manifested as conduction disorders, and drug-induced thrombocytopenia (Table 4.). 
Eight of the patients of that group required repeated (second or third) hospitalization, 
due to some of the complications of malaria requiring longer hospital treatment or 
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appearing with a several weeks delay, as it was the case with drug-induced 
thrombocytopenia, meningoencephalitis  or psychoorganic dementive syndrome. 
In 4 cases the disease was fatal; the mortality in the studied group of patients was 
2.4%. Three of the patients were seamen and one was a traveler. In three patients death 
was caused by multi-organ failure in the course of tropical malaria, with the direct cause 
defined as  treatment-resistant renal failure. In one case death resulted from cerebral 
malaria (Table 5). 
Prognostic indicators of severe malaria in our cases are listed in Table 6.  The 
analysis included such parameters as patient’s age, level of parasitemia, presence of 
schizonts in peripheral blood, elevated white blood cell count, and appearance of 
malaria pigment in granulocytes. None of the patients demonstrated a full set of factors 
regarded as signs of poor prognosis. 
Table 3. Signs and symptoms of severe malaria in 36 patients hospitalized in 
Gdynia, and the number of fatal cases 
 
Sign/symptom No. of patients No. of deaths 
Hyperparasitemia 
Disorders of consciousness 
Severe anemia 
Marked jaundice 
Shock (hypovolemic, septic) 
Renal failure 
Hyperpyrexia  
Disseminated intravascular coagulation 
Cerebral malaria 
ARDS (pulmonary edema) 
Blackwater fever (dark-coloured urine) 
Prostration 
Acidosis 
Generalized seizure 
Hypoglycemia 
19 
18 
13 
7 
7 
7 
3 
4 
3 
3 
2 
2 
1 
1 
0 
 
 
 
 
 
3 
 
 
1 
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Table 4. Complications and permanent sequelae of severe malaria among 169 patients 
treated in Gdynia 
Fatal outcome, complications and sequelae No. of patients 
Deaths 
Myocardial ischemia, arrhythmia and conduction disorders  
       (due to myocardial hypoxia) 
Myocarditis 
Blackwater fever 
Encephalitis 
Psychoorganic dementive syndrome 
Psychosis 
Drug-induced thrombocytopenia (halofantrine) 
4 
3 
 
2 
2 
2 
2 
2 
1 
Table 5. Life-threatening signs and symptoms of severe malaria – data on 4 fatal cases 
Signs and symptoms 
Patients 
L.L. W.J. C.S. R.M. 
Neurological  
Deep coma 
Disorders of 
consciousness 
Coma 
Disorders of 
consciousness 
Disorders of 
consciousness 
Generalized seizures  +   
Signs of decortication 
(opisthotonos)     
Increased intracranial 
pressure (retinal edema)     
Cardiovascular  
Shock     
Pulmonary edema +   + 
Cardiac arrhythmia     
Myocardial ischemia (ECG)   +  
Renal  
Rapidly progressing renal 
failure 
+  + + 
Hemorrhagic  
DIC  +   
Liver damage     
Marked jaundice +  + + 
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Table 6. Prognostic factors in 4 cases of severe malaria with fatal outcome 
 
Patients L.L W.J. C.S.. C.S. 
Age < 3 years and > 70 years 35 44 36 32 
Hyperparasitemia (> 5 %) 22 10 33 2.5 
Peripheral schizontemia + + + - 
Polymorphonuclear leukocytosis 9.8 9.4 3.6 5.2 
Leukocytes with malaric pigment 
(> 5%) - - - + 
 
Table 7. Laboratory examination results in 4 fatal cases of falciparum malaria  
 
Parameters 
Patients 
L.L. W.J. C.S. R.M. 
Abnormal 
blood count 
RBC (109/L) 
Hemoglobin (g/dL) 
Platelets (106/L) 
2.67 
8.3  
26000 
4.81 
14.4 
35000 
2.35 
8.0 
15000 
5.07 
16.1 
30000 
Elevated renal 
parameters 
Urea (mg/dL) 
Creatinine (mg/dL) 
288 
6.2 
131 
2.2 
174 
5.8 
114 
6.9 
Metabolic 
acidosis  + –  + + 
Marked 
jaundice 
Bilirubin (mg/dL) 
AlAT (IU/ L) 
AspAT (IU/L) 
11.8 
118 
248 
2.7 
92 
112 
22.1 
112 
194 
9.5 
102 
305 
Blood 
coagulation 
disorders 
AT III (%) 
D-Dimer, FDP (µg/dL) 
60 
FDP>40 
58 
>1000 
 
>10000 
52.9 
>10000 
Hypoglycemia Glucose in whole blood below 40 mg/dL – – – – 
High serum 
concentration 
of TNF-α 
 
   + 
 
Considering the cases concluded with patient’s death, A list of “alarming” results of 
laboratory tests in fatal cases is presented in Table 7. Two patients developed severe 
anemia, which resulted of the high-level parasitemia (22 and 33% in red cells), three 
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patients had metabolic acidosis,  and also three patients developed hyperbilirubinemia, 
which reached the level of 22.1 mg/dL in one of them. 
The application of PCR testing allowed us to diagnose mixed infections in 6 of the 
patients. 
DISCUSSION 
Polish seafarers have been medically examined and treated in our Institute for 
decades, therefore those of them who were infected with malaria were a large group of 
our patients. 
Also patients of other professions were treated in our department, from both Poland 
and other countries. Among them, there were also missionaries who spent many year in 
the tropics. 
During the recent 10-15 years, increasing numbers of citizens of this country have 
traveled as tourists to many areas of the world, also to malaria endemic regions. 
Unfortunately, most of them are unaware of the health risks connected with traveling to 
the tropics, and they do not care for malaria prevention and chemoprophylaxis. Some of 
them take drugs irregularly or in  inadequate doses.This problem is known also in other 
European countries and in the USA (6). 
 Among patients treated for malaria during the last 15 years, there has been a change 
observed in both relative numbers of representatives of different professions and their 
motives for visits and stays in the tropics. 
In the period 2001-2005, we had  in our Department less patients treated for malaria 
each year and among them also less seafarers. This may be due to the increasing 
possibility of treatment of tropical diseases not only in our Center but also in several 
other medical centers in Poland; and to gradually wider use of antimalarials  by 
travelers. 
American data indicate that the percentage of tourists traveling in groups and 
missionaries among all patients treated for malaria, 8.5% and 10.6%, respectively, 
decreased in the years 1989-2001 as compared to 1969-89, while the percentages of 
individual tourists and business travelers increased – 21.3 and 19.2% (7). This may 
indicate which groups of travelers are exposed to malaria infection, and which of them 
shall be regularly informed about methods of malaria prevention. 
 In the USA, in the period 1963-2001, mortality due to malaria was determined as 0-
4.4%, with mean of 0.9%, which is less than in our study; however, mortality rates 
similar to that in our study were reported in studies carried out in other European 
countries. In Greece, in the period 1989-1995 there were 109 cases of malaria recorded, 
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with no resulting deaths at all. On the other hand, in Germany there were 3747 patients 
treated for malaria, with mortality rate equal to 3.6% (3). 
In severe malaria, typical  are signs indicating for multi-organ failure. A number of 
parasitic toxins released in the course of infection lead to activation of several factors of 
the immune system, especially cytokines, like TNF and pro-inflammatory interleukins 
(IL), as well as free radicals and nitric oxide. As a result of the destructive actions of 
these substances, damage of endothelial cells and tissues of the host ensues. Research 
conducted in African children with severe malaria proved that elevated levels of pro-
inflammatory cytokines: TNF-α, interleukin-1β and interleukin-6 are associated with 
cerebral malaria (8), while relatively low levels of anti-inflammatory cytokine IL-10 are 
found in patients with severe anemia in the course of malaria. Another research, carried 
out in adult patients in Vietnam also revealed correlation of elevated cytokine serum 
levels with severe course of the disease and multi-organ failure. However, Day et al. (9) 
have not detected such relationship in adult subjects with cerebral malaria. 
In cerebral malaria severe intravascular changes develop in the vessels of the central 
nervous system due to sequestration of parasitized red blood cells (pRBCs) as well as 
functional and morphological changes within the endothelial cells of cerebral vessels as 
a result of their interaction with platelets, monocytes, lymphocytes and dendrocytes 
accumulating within cerebral microcirculation (10). Generalized activation of vascular 
endothelial system is confirmed by the presence of activation markers, with 
significantly increased concentrations of ICAM-1 and E-selectin and their deposition 
within cerebral blood vessels (11). In humans ICAM-1 was identified as a vascular 
endothelial ligand for erythrocytes infected with P. falciparum. Assessment of these 
indicators is now possible for research purposes only and has no practical application in 
clinical management of patients with malaria. 
It is important to mention that the diagnosis of cerebral malaria should not be 
established in just every case of consciousness disorders or neurological symptoms 
indicating affection of the central nervous system. In our study cohort,  there were two 
cases (both of them seamen) of meningoencephalitis of undetermined etiology. 
Diagnostic tests were performed and infections with Polio, Coxackie B, Echo, Herpes, 
CMV, rubella, HIV, and arboviruses as well as toxoplasmosis were ruled out. In one of 
the two patients, disorders of consciousness and acute psychosis with subsequent 
presence of meningeal signs and typical inflammatory changes in cerebrospinal fluid 
and CT-scan of the head developed within the first days of treatment of malaria. The 
outcome in this case was psychoorganic dementive syndrome and permanent 
impairment of health. The illness was classified as a case of occupational disease and 
the patient was granted health pension due to his disability preventing him to continue 
his employment (12). In the other patient cerebral and meningeal symptoms with 
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accompanying fever and inflammatory changes in the cerebrospinal fluid appeared 3 
weeks after completion of the treatment. Also in this case the etiological factor could 
not be determined. After several months full recovery was observed in this patient. It is 
possible that both the patients developed reactive immunological meningoencephalitis 
in response to Plasmodium falciparum infection. Case reports exist describing this type 
of inflammatory changes within the CNS in the course of malaria, which are sometimes 
referred to as acute disseminated encephalomyelitis, ADEM (13). 
Results of some laboratory tests may be of prognostic value. Marked anemia, most 
frequently related to high-level parasitemia, thrombocytopenia which may be inter alia 
the effect of disseminated intravascular coagulation (DIC), polymorphonuclear 
leukocytosis, disorders within the plasma coagulation system, elevated and rapidly 
increasing levels of renal function parameters, high level of plasma bilirubin indicating 
severe lesion of the liver, metabolic acidosis and hypoglycemia (observed much more 
frequently in residents of endemic regions, particularly in children, than in non-immune 
individuals), are important indicators of unfavourable course of the disease – 
progressing up to the point of multi-organ failure (14). 
Four of our cases of malaria were fatal.  In one case the cause of death were cerebral 
complications, while in three others death resulted from multi-organ failure with renal 
failure being the dominant clinical manifestation. Malaria of severe, lethal course is 
related to the activation of diverse substances of endothelial origin. Parasitic endotoxins 
cause damage of the endothelium, which results in: increased vascular permeability, 
escape of protein to the extravascular space, abnormal vasodilation, a decrease in 
arterial blood pressure and depression of the myocardium. These changes lead to 
hypovolemia and deterioration of organ perfusion, which is particularly dangerous for 
such organs as kidneys or brain. Some phenomena also occur which are specific for P. 
falciparum malaria e.g. constriction of microcirculation vessels as a result of the action 
of an adhesive protein found on the surface of parasitized erythrocytes. What is more, 
plasticity of parasitized erythrocytes is less than normal, which impairs their ability to 
adjust their size to the diameter of fine blood vessels of microcirculation (15). As a 
result of these processes is local intravascular coagulation ensues, which in the case of 
kidneys may lead to irreversible organ damage. 
The assessment of cytokine or TNF-α levels are not widely available; therefore, they 
have neither become an element of standard evaluation and monitoring of the course of 
malaria nor an accepted prognostic factor. A few attempts to use TNF-α inhibitors in 
treatment of patients with severe forms of malaria have been made within experimental 
studies only (16). In one of the fatal cases of malaria observed in our study, high serum 
concentration of TNF-α was detected.  Further research is in progress to explore the 
significance of such findings. 
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 CONCLUSIONS 
  
• Tropical malaria  may be the cause of severe complications. In our patients, 
clinical manifestation of this type of the disease were  mostly symptoms of  
multi-organ failure. 
• Cerebral dysfunction and rapidly progressing renal failure are the highest risk 
of death of the patient. 
• In some of our patients, malaria left behind persistent sequelae. Such 
complications may lead to permanent disability. 
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